arrow
Back
E

Elena Castro

Hospital 12 de Octubre

40H-index
245Paper Count
8.7KCitation Count
Published Papers 95
Publication Date
Advancing Metastatic Prostate Cancer Care: Best Practices And Future Directions In Molecular Testing
err2026-06-13
err0
errOAAI
errElena Castro; Jie-Fu Chen; Ben Lowentritt; Partha Das; Ramin Dowlati; David Olmos
errShare
errSave
Phase III randomized studies of mevrometostat and enzalutamide in metastatic prostate cancer (MEVPRO-1 and MEVPRO-2): trial protocols
err2026-05-10
err0
PREAI
errNeal D. Shore; Karim Fizazi; Michael Thomas Schweizer; Elena Castro; Arun A. Azad; Daniel J. George; Karine Martins da Trindade; Hao Zeng; Nitin Shrivastava; Svitlana Tonkovyd; Amy Bock; Srilakshmi Nekkalapudi; Yiyun Tang; Stella Lin; Neeraj Agarwal
errShare
errSave
RADIOGRAPHIC PROGRESSION-FREE SURVIVAL AS A MEANINGFUL ENDPOINT IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC): THE TALAPRO-2 RANDOMIZED CLINICAL TRIAL
err2026-05-01
err0
PREAI
errAgarwal, Neeraj; Paganelli, Stefanie; Wang, Di; Haltner, Anja; Kirker, Melissa; Su, Neo; Chang, Jane; Samjoo, Imtiaz A.; Castro, Elena
errShare
errSave
Radiographic progression-free survival as a surrogate endpoint for overall survival in first-line ARPi naive metastatic castration-resistant prostate cancer
err2026-02-01
err0
errOAAI
errCastro, Elena; Paganelli, Stefanie; Wang, Di; Haltner, Anja; Niyazov, Alexander; Chang, Jane; Samjoo, Imtiaz A.; Barata, Pedro C.
errShare
errSave
Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
err2025-12-18
err0
PREAI
errJ. Walz; G. Attard; A. Bjartell; P. Blanchard; E. Castro; E. Compérat; L. Emmett; S. Fanti; V. Fonteyne; S. Foulon; S. Gillessen; G. Gravis; N.D. James; D.E. Oprea-Lager; P. Ost; A. Padhani; C. Parker; R.M. Renard-Penna; M.A. Rubin; F. Saad
errShare
errSave
Prostate cancer
err2025-12-16
err0
PREAI
errValérie Fonteyne; Alison Tree; Elena Castro; Karim Touijer; Jochen Walz
errShare
errSave
PARP Inhibitors in Prostate Cancer: Broad Use or Patient Selection?
err2025-12-05
err0
PREAI
errIgnacio González-Ginel; Alfredo Rodriguez-Antolin; David Olmos; Elena Castro
errShare
errSave
Venous thromboembolic event risk with PARP inhibitors in solid tumors: a systematic review and meta-analysis
err2025-09-29
err0
errOAAI
errS.C. Yazgan; E. Yekedüz; E. Akkuş; M. Sun; S. Gillessen; K. Fizazi; R.R. McKay; C. Ay; E. Castro; N. Agarwal; T.K. Choueiri; Y. Ürün
errShare
errSave
Prostate cancer germline variants with therapeutic implications
err2025-07-30
err0
PREAI
errMasoud Bitaraf; Elena Castro; Nima Sharifi
errShare
errSave
Evaluating Treatment Efficacy in Metastatic Hormone-sensitive Prostate Cancer Patients with Visceral Disease: A Systematic Review and Network Meta-analysis
err2025-07-10
err0
errOAAI
errFabiano Flauto; Giuseppe Neola; Carmine Caso; Alessio Signori; Giuseppe Fornarini; Sarah Scagliarini; Sabrina Rossetti; Felice Crocetto; Francesco Grillone; Fabrizio Di Costanzo; Pasquale Rescigno; Vincenza Conteduca; Giuseppe Luigi Banna; Orazio Caffo; Marco Maruzzo; Roberto Iacovelli; Elena Castro; Roberto Bianco; Alberto Servetto; Luigi Formisano
errShare
errSave
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer − a systematic review and expert consensus
err2025-07-09
err0
PREAI
errConstantinos Zamboglou; William De Doncker; Andreas Thomas Christoforou; Stefano Arcangeli; Alejandro Berlin; Pierre Blanchard; Glenn Bauman; Riccardo Campi; Elena Castro; Ananya Choudhury; Alan Dal Pra; Cédric Draulans; Neil Desai; Konstantinos Ferentinos; Giulio Francolini; Silke Gillessen; Anca-Ligia Grosu; Juan Gómez Rivas; Tobias Hoelscher; George Hruby; Simon Spohn
errShare
errSave
Breast cancer germline multigene panel testing in mainstream oncology based on clinical–public health utility: ESMO Precision Oncology Working Group recommendations
err2025-06-15
err0
PREAI
errC. Turnbull; M.I. Achatz; J. Balmaña; E. Castro; G. Curigliano; C. Cybulski; S.M. Domchek; D.G. Evans; H. Hanson; N. Hoogerbrugge; P.A. James; A. Krause; K.L. Nathanson; J. Ngeow Yuen Yie; M. Robson; M. Tischkowitz; B. Westphalen; W.D. Foulkes
errShare
errSave
The role of radium-223 in the evolving treatment landscape of metastatic castration-resistant prostate cancer: A narrative review
err2025-06-01
err0
PREAI
errPinto, Alvaro; Dominguez, Mario; Gomez-Iturriaga, Alfonso; Rodriguez-Vida, Alejo; Vallejo-Casas, Juan Antonio; Castro, Elena
errShare
errSave
Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE Trial
err2025-05-05
err0
errOAAI
errKim N. Chi; Elena Castro; Gert Attard; Matthew R. Smith; Shahneen Sandhu; Eleni Efstathiou; Guilhem Roubaud; Eric J. Small; Andrea Pereira de Santana Gomes; Dana E. Rathkopf; Marniza Saad; Howard Gurney; Wonho Jung; Won Kim; Shiva Dibaj; Daphne Wu; Jenny Zhang; Angela Lopez-Gitlitz; Peter Francis; David Olmos
errShare
errSave
Matching-adjusted indirect comparison of talazoparib plus enzalutamide versus abiraterone acetate and docetaxel in mCRPC
err2025-03-01
err0
errOAAI
errCastro, Elena; Wang, Di; Walsh, Sarah; Craigie, Samantha; Haltner, Anja; Nazari, Jonathan; Niyazov, Alexander; Samjoo, Imtiaz A.
errShare
errSave
Real-world treatment patterns and genetic testing in a metastatic castration-resistant prostate cancer setting in Europe
err2025-03-01
err0
errOAAI
errCastro, Elena; Orji, Chinelo; Ribbands, Amanda; Butcher, Jake; Walley, Maria; Li, Weiyan; Ghate, Sameer R.
errShare
errSave
errShare
errSave
Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study
err2025-01-09
err0
errOAAI
errO'Sullivan, Joe M.; Heinrich, Daniel; Castro, Elena; George, Saby; Dizdarevic, Sabina; Baldari, Sergio; Essler, Markus; Jong, Igle Jan de; Lastoria, Secondo; Hammerer, Peter G.; Tombal, Bertrand; James, Nicholas D.; Meltzer, Jeff; Sandstrom, Per; Sartor, Oliver
errShare
errSave